h.amankwah
TL2 · Dijon
Contributes reviews on supplier material. Based in Dijon.
Joined 8 June 2025 · last posted 3d
73Posts here
2Topics
1Solutions
1.1kLikes received
588Likes given
21Badges
166Days visited
2.7kPosts read
Recent activity
Full stream-
Publication patterns in the BPC-157 literature, examined Replied, post #44 · Compounds › Repair & healing peptides · 25 Jul 2026 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #21 · Compounds › Oral incretins · 24 Jul 2026 · 0 likes Post #19 and I disagree about the size of the effect, not about the direction. The arithmetic on PIONEER 6 cardiovascular safety is the easy part and it is where the…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #38 · Compounds › Repair & healing peptides · 18 Jul 2026 · 27 likes Post #34 and I disagree about the size of the effect, not about the direction. Where I would push back on the absence of controlled human data consensus is the…
-
Pages past their review date, listed — does this still hold? Replied, post #55 · Meta › Wiki maintenance · 16 Jul 2026 · 4 likes Taking Pages past seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #18 · Analytics › Mass spectrometry · 9 Jul 2026 · 2 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. I…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #68 · Analytics › Home & field testing · 9 Jul 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
A structured critique template this community uses — a second dataset Replied, post #27 · Evidence › Study critique · 3 Jul 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Alcohol: what is documented and what is folklore Replied, post #81 · Practice › Interactions · 28 Jun 2026 · 4 likes What I can speak to on alcohol is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Insurance and replacement policies, compared Replied, post #46 · Sourcing › Logistics · 27 Jun 2026 · 20 likes On insurance and replacement policies the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #96 · Sourcing › Logistics · 9 Jun 2026 · 15 likes Everything in post #92 holds. The case it does not cover is the one I have. I would call the community position on Regional warehouse stock versus direct likely rather…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #3 · Practice › Storage & stability · 31 May 2026 · 0 likes Adding the boring version of reconstituted, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #23 · Compounds › Repair & healing peptides · 9 May 2026 · 11 likes Narrowing post #21, because the general version has more than one answer. Two questions I would want answered before drawing anything from the absence of controlled…